NASHVILLE, Tenn. / Dec 06, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it collected 13,136 pounds of unused or expired medications during its fifth annual “Crush the Crisis” prescription drug take back day on October 28, 2023. HCA Healthcare has now collected more than 67,500 pounds of medication since launching “Crush the Crisis” as an enterprise initiative in 2019.
“At our core, we are people taking care of people, and ‘Crush the Crisis’ is a great example of our dedication to that goal,” said Dr. Randy Fagin, chief medical officer of HCA Healthcare’s National Group. “We are proud to have worked alongside our colleagues, neighbors and local law enforcement teams at more than 130 collection sites to collect unused or expired medication before it could fall into the wrong hands.”
This year, all 15 HCA Healthcare U.S. divisions participated alongside local law enforcement in a “Crush the Crisis” prescription drug take back day to raise awareness about the dangers of prescription drug misuse and the importance of proper disposal of unused or expired medications. An estimated 9 million doses of medication were collected at 132 collection sites across 15 states. HCA Healthcare’s “Crush the Crisis” events were held in alignment with the Drug Enforcement Administration’s (DEA) National Prescription Drug Take Back Day, which collected 599,897 pounds of medication.
HCA Healthcare facility events with the greatest amount of medication collected this year include:
Additionally, HCA Healthcare uses data from approximately 37 million annual patient encounters to help continuously improve care. The organization uses the science of “big data” in its efforts to reduce prescription drug misuse and transform pain management, with initiatives in surgical, emergency and other care settings, including:
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 183 hospitals and approximately 2,300 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its more than 37 million annual patient encounters to advance science, improve patient care and save lives.
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
Last Trade: | US$335.55 |
Daily Change: | -5.07 -1.49 |
Daily Volume: | 974,226 |
Market Cap: | US$84.990B |
February 20, 2025 February 18, 2025 October 25, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load